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Background. Prions are known to cause transmissible spongiform encephalopathies (TSE) after accumulation in the central
nervous system. There is increasing evidence that prions are also present in body fluids and that prion infection by blood
transmission is possible. The low concentration of the proteinaceous agent in body fluids and its long incubation time
complicate epidemiologic analysis and estimation of spreading and thus the risk of human infection. This situation is
particularly unsatisfactory for food and pharmaceutical industries, given the lack of sensitive tools for monitoring the
infectious agent. Methodology/Principal Findings. We have developed an adsorption matrix, Alicon PrioTrapH, which binds
with high affinity and specificity to prion proteins. Thus we were able to identify prion protein (PrPC)–the precursor of prions
(PrPSc)–in milk from humans, cows, sheep, and goats. The absolute amount of PrPC differs between the species (from mg/l
range in sheep to ng/l range in human milk). PrPC is also found in homogenised and pasteurised off-the-shelf milk, and even
ultrahigh temperature treatment only partially diminishes endogenous PrPC concentration. Conclusions/Significance. In
view of a recent study showing evidence of prion replication occurring in the mammary gland of scrapie infected sheep
suffering from mastitis, the appearance of PrPC in milk implies the possibility that milk of TSE-infected animals serves as source
for PrPSc.
Citation: Franscini N, Gedaily AE, Matthey U, Franitza S, Sy M-S, et al (2006) Prion Protein in Milk. PLoS ONE 1(1): e71. doi:10.1371/
journal.pone.0000071
INTRODUCTION
Prion protein was detected in attempts to identify the infective
agent of TSE [1,2]. The finding that prion protein is present in
normal and TSE-infected brain at similar levels [3,4] suggests that
the ‘‘cellular’’ prion protein (PrPC) constitutes a precursor of the
‘‘scrapie’’ prion protein (PrPSc) causing TSE such as bovine
spongiform encephalopathy (BSE) in cattle or Creutzfeldt-Jakob
disease (CJD) in humans. There is convincing evidence that the
transition from precursor protein to infectious prion is due to
a major conformational transition [5].
Prion protein is highly conserved among mammals [6]. It is
primarily synthesized in cells of the central nervous system [7], but is
also abundantly expressed in several peripheral tissues [8,9]. An
amino-terminal signal sequence targets prion protein to the
endoplasmatic reticulum, where it transits the Golgi and ultimately
reaches the external surface of the cell membrane [10]. There it is
attached to a carboxy-terminal glycosyl phosphatidylinositol anchor
[11]. The mature bovine protein of 217 amino acids contains two
consensus acceptor sites for addition of N-linked polysaccharides [12].
Prion proteins (PrPC and PrPSc) have been detected in the
cellular fraction of blood [13–17], but so far not in milk [18–21].
Considering that milk and milk products represent a major
component of human nutrition it seems of particular importance
to analyze milk for the presence of prion proteins. A first step in
this direction is to determine the amount of PrPC in milk of healthy
animals. If milk contains a significant amount of PrPC, this could
indicate that PrPSc might be present in so far undetectable
amounts in milk of TSE infected animals. However, the high
concentration of total protein (about 40 mg/ml) and the high
amount of lipids (about 35 mg/ml) in the milk make prion protein
analysis by common biochemical methods demanding. We have
therefore developed an adsorption matrix, Alicon PrioTrapH,
which binds with high affinity and specificity to prion proteins
PrPC and PrPSc. The exceptional binding properties of Alicon
PrioTrapH result from hydrophilic and hydrophobic surface
clusters that recognize different prion protein epitopes, allowing
quantitative enrichment of extreme low quantity of prion proteins
in body fluids and in biological tissues.
RESULTS
The detection of native PrPC after enrichment from 10 ml milk
from cow, sheep, goat, and human using Alicon PrioTrapH is
shown in figure 1. In cow milk three PrPC isoforms are observed
with an apparent molecular mass of about 34 kD, 30 kD, and
27 kD corresponding to diglycosylated, monoglycosylated, and
unglycosylated PrPC, respectively. In some preparations mono-
glycosylated PrPC appears as a double band, indicating that the
two glycosylation sites may be linked to different carbohydrates.
The apparent molecular mass of unglycosylated PrPC is slightly
higher when compared to a recombinant bovine PrP(25–241)
standard at 26 kD, indicating that native PrPC in milk contains
a glycosyl phosphatidylinositol anchor [11]. About the same
distribution of PrPC isoforms is observed for sheep, goat, and
human milk, although the total amount of native PrPC
significantly differs between the species. The relative ratio of
sheep/cow/goat/human PrPC is estimated at 100/20/4/1. From
experiments performed on sequential incubations with Alicon
PrioTrapH the total concentration of PrPC in fresh cow milk can
be estimated to be about 200 pg/ml. Taking into account the
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relative ratios of PrPC in milk of different species, fresh sheep milk
and goat milk contain about 1 ng/ml and 40 pg/ml PrP,
respectively. Human breast milk contains less than 10 pg/ml
PrPC. The concentration of PrPC in Swiss off-the-shelf milk is
reduced when compared to fresh milk, but prion protein can
clearly be detected (Figure 1). About the same concentration of
PrPC was measured for organic farm milk and non-organic farm
milk as well as for pasteurized and ultra-high temperature (UHT)
treated milk (data not shown).
To confirm specificity of immunochemical detection of PrPC in
milk, we compared different anti-PrP monoclonal antibodies, which
are directed against non-overlapping epitopes (Figure 2): PrP2mab
8B4 binds to residues 37244 of mouse PrP [22]; mAB 6H4 targets
residues 1442152 [23]; and PrP2mab 8H4 binds to residues
1752185 [24]. The three antibodies recognize the same proteins
and thus confirm the presence of PrPC in milk. In control experi-
ments, with non-PrP antibodies, e.g., anti-Tau protein monoclonal
antibody (Chemicon International) (Figure 2) and anti-Ab mono-
clonal antibody (Calbiochem, Germany; data not shown), none of
the PrPC isoforms was detected, thus confirming binding specificity
of the anti-PrP monoclonal antibodies. An interesting observation
with regard to antibody 8B4 is its ‘‘clear’’ detection profile when
compared to 6H4 and 8H4 antibodies. This can be rationalized by
8B4 not recognizing a variety of carboxy-terminal fragments of milk
PrPC, which appear as smear in the Western Blot.
We further compared the glycoforms of native prion protein in
cow milk with those of bovine brain, a tissue where prion protein
expression is well characterized. The glycoforms were identified by
digestion with PNGase (Figure 3), an enzyme that cuts off
oligosaccharides from N-linked glycoproteins, e.g., the two N-
linked sugars of PrPC [12]. After partial cleavage with PNGase the
upper PrP-isoform in the Western Blot representing diglycolysated
PrPC (34 kD) disappears in favour of monoglycosylated (30 kD)
and nonglycosylated PrPC (27 kD). In parallel, there seems to be
a small shift from the higher molecular weight monoglycosylated
form to the lower molecular weight form. A slight downshift of the
monoglycosylated PrPC is also observed for brain homogenate
after PNGase treatment (Figure 3). The diglycosylated PrPC
isoforms differ slightly in molecular mass, indicating that
carbohydrate structure of PrPC in milk and brain may not be
identical. More stringent reaction conditions result in complete
truncation of carbohydrates from PrPC. Most importantly, the
apparent molecular masses of nonglycosylated PrPC in milk
exactly matches with that of the corresponding PrPC in brain
homogenate.
Alicon PrioTrapH can also be applied for elimination of prion
protein from milk. As shown in Figure 4, after the first treatment of
10 ml milk with Alicon PrioTrapH more than 95% of endogenous
PrPC was already removed, and after the second treatment PrPC
was completely eliminated. However, the overall protein concen-
Figure 1. Detection of native PrPC in milk of human and animals. A volume of 10 ml fresh, ultra-high temperature treated (UHT) and pasteurised
(Past) milk were enriched for PrPC using Alicon PrioTrapH technology. Concentrated PrPC was analyzed by Western Blotting using PrP2mab 8B4
(Alicon AG). The molecular weight markers are indicated. Recombinant bovine PrP(252241) (Alicon AG) was used as a standard.
doi:10.1371/journal.pone.0000071.g001
Figure 2. Specific binding of anti-PrP monoclonal antibodies to milk PrPC. Various anti-PrP monoclonal antibodies were used for detection of PrPC
in fresh cow milk. A Tau-1 protein-specific monoclonal antibody was used as a negative control. Recombinant bovine PrP(252241) (Alicon AG) and
recombinant Tau-1 protein (Chemicon International) were used as a standard.
doi:10.1371/journal.pone.0000071.g002
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tration (measured by bicinchoninic acid assay, Pierce) was constant
with about 40 mg/ml before and after PrPC elimination. The
protein composition of milk as analyzed by SDS PAGE (Figure 4)
was not affected either. Prion protein was also completely
removed, when milk was spiked with PrPSc from mouse Rocky
Mountain Laboratory (RML) brain homogenate (data not shown).
Thus, Alicon PrioTrapH can be used for enrichment and detection
of overall prion protein in milk, but also for complete removal of
prions.
DISCUSSION
Milk contributes 13% to the worldwide protein supply for humans.
World milk production ranges around 500 million tons a year.
Before fresh milk reaches the consumer, it is usually homogenized
to reduce fat particle size in order to increase digestibility of the
milk and heated. Surprisingly, pasteurisation (heating for 30 sec-
onds to 72uC) and ultra-high temperature treatment (heating for
1–4 seconds to 135uC) only leads to a partial reduction of the
amount of PrPC. This supports the observation that PrPC is highly
stable in milk. Thus, the heating procedures used to inactivate
DNA-containing pathogens are not sufficient to eliminate
endogenous prion proteins.
The presence of PrPC in blood has been documented [14,15],
and is confirmed by our own unpublished observations. To
produce one liter of milk, about 400 to 500 liters of blood must
pass through the udder of a cow. It is thus possible that the PrPC
found in milk derives from blood cells or, alternatively, has been
secreted from glandular epithelial cells. Cell types that have been
identified in milk from healthy cows are mainly macrophages, and
other leucocytes. However, in our assay cells are completely
removed by centrifugation. Therefore, the recovered PrPC is not
cell associated but most likely binds to other proteins or lipids
resulting in stable molecular complexes. The fact that milk
contains full-length PrPC, very likely comprising the glycolipid
anchor, indicates that prion protein was originally cell-bound and
does not represent any of the amino-terminal truncation products
of PrPC known to be released from normal cells under
physiological conditions [25]. The detection of such a considerable
expression of cell membrane bound or derived PrPC in milk
constitutes one of the key requirements for the generation of
infectious prions in the udder of infected animals.
Over the last 10 years, scientific groups, risk assessment
agencies, and public health organizations have debated the TSE
risk for milk and milk products [26,27]. Epidemiological and
bioassay data so far available have not provided evidence for milk
to harbour prion infectivity and infectious prions have as yet not
been detected by bioassays in the milk, colostrum or udder of
clinical BSE cases in cow [18–21]. However, a recent statement of
the European Food Safety Authority affirmed that based on
a number of observations from research data, there are indications
that infectivity in the milk from small ruminants can not be totally
excluded [28]. Furthermore, the exclusion of animals with mastitis,
an inflammation of the mammal gland, being able to destabilize
the blood-milk barrier, is considered a measure able to reduce but
not to eliminate the potential contamination risk [28]. The
rational of this conclusion is confirmed by a recent study showing
that in sheep naturally affected with both scrapie and lymphocyte
or lymphofollicular mastitis, PrPSc accumulation was present in
lymphoid follicles adjacent to milk ducts [29]. At least in natural
sheep scrapie, prion replication can occur following a lymphotropic
virus infection in the inflamed mammary gland. This study has not
detected PrPSc or prion infectivity in milk itself. However, since
under such inflammatory conditions, the total number of immune
cells increases in milk of animals, it might be possible that
infectious PrPSc is also passing through and reaches the milk. In
this context milk from such animals could possibly be responsible
for the spread of scrapie from the ewes to their offspring in affected
sheep or goat flocks. Moreover, sheep and goat milk could also
constitute a TSE exposure risk for mammals (humans) consuming
these products.
The former Scientific Steering committee of the European
Commission and the European Food Safety Authority recommend
that research should intensify on the safety of milk of small
ruminants with regard to TSE risk. Limited new data are expected
to be published in the near future and there is still little research
initiated in this area [28]. The Alicon PrioTrapH technology opens
a new avenue for studying the biochemical characteristics of prion
Figure 3. Glycoform patterns of milk and brain PrPC. Alicon PrioTrapH-enriched PrPC from cow milk and brain homogenate was treated with PNGase
or PNGase/SDS before Western Blotting using PrP2mab 8B4.
doi:10.1371/journal.pone.0000071.g003
Figure 4. Elimination of PrPC from milk. PrPC from 10 ml fresh cow
milk was detected as described in figure 1, followed by two consecutive
PrPC removal steps, where the milk supernatant was incubated with
Alicon PrioTrapH filtration resin for 30 min before immunochemical
detection. The total amount of milk protein was analyzed by Silver Stain
analysis.
doi:10.1371/journal.pone.0000071.g004
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protein in milk and thus may contribute to offer a feasible
approach to perform an appropriate study on the milk safety with
regard to TSE risk.
MATERIALS AND METHODS
Preparation of milk samples
Fresh milk was obtained from healthy individuals and transported
at 4uC. Cow UHT milk, sheep and goat pasteurised milk were
obtained from the Swiss market. Each sample was prepared from
10 ml milk, centrifuged at 30006 g for 10 min to ensure complete
removal of cells.
Preparation of brain homogenate
10% (w/v) bovine brain homogenate was prepared in 100 mM
Tris-HCl pH 7.5 containing 2% sodium lauryl sarcosinate. This
solution was diluted in 100 mM sodium phosphate buffer pH 8
containing 0.5% NP-40 to obtain 1% (w/v) brain homogenate.
Concentration of milk PrPC
The milk supernatant was stirred for 30 min in the presence of
Alicon PrioTrapH. The resin was centrifuged for 2 min at
20006 g and washed three times at RT with 10 ml washing
solution containing 100 mM sodium phosphate buffer pH 8.
Immunochemical PrPC detection
Concentrated milk and brain PrPC was denaturated in SDS
sample buffer and heated at 70uC for 10 min and at 95uC for
5 min, respectively. Samples were applied to a 12% SDS
polyacrylamide gel for electrophoresis and subsequently trans-
ferred to a PVDF membrane. The membrane was blocked with
2% ECL AdvanceTM blocking agent (Amersham) if probed with
8B4 antibody or 1% bovine serum albumin if probed with other
antibodies used in this study. 8B4 antibody was incubated at
a concentration of 450 ng/ml, 8H4 at 85 ng/ml, 6H4 at 285 ng/
ml, and anti-Tau-1 at 50 ng/ml. Sheep anti-mouse IgG
horseradish peroxidase-conjugated secondary antibody (Amer-
sham) was incubated at a 1/20,000 dilution. The immunoreac-
tivity was visualized by chemiluminesecence detection following
the manufacture’s instruction (ECL Advance Western Blot
detection Kit, Amersham).
PNGase treatment of milk and brain PrPC
For PNGase treatment prion protein extracted from 10 ml cow
milk or 10 ml of 1% (w/v) cow brain homogenate was incubated
for 12 h at 37uC in buffer containing 100 mM sodium phosphate,
10 mM Tris-HCl, 1% NP-40, 1% MEGA-8, pH 8, and 1.5 units
of N-Glycosidase F (Roche). Under more stringent cleavage
conditions, proteins were denatured by heating for 10 minutes at
100uC in the presence of 0.5% SDS before treatment with 4 units
of N-Glycosidase F.
Total milk protein detection
A milk volume corresponding to 40 mg total protein (1 ml) was
heated in SDS loading buffer at 70uC for 10 min. After
electrophoresis on a 12% SDS polyacrylamide gel, the proteins
were detected by silver staining (SilverSNAP Stain kit II, Pierce).
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